Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 5/2013

01-10-2013 | Letter to the Editor

Type 1 diabetes mellitus and celiac disease: usefulness of gluten-free diet

Authors: Paola Pascolo, Elena Faleschini, Giorgio Tonini, Alessandro Ventura

Published in: Acta Diabetologica | Issue 5/2013

Login to get access

Excerpt

To the Editor, …
Literature
1.
Picarelli A, Di Tola M, Sabbatella L, Mercuri V, Pietrobono D, Bassotti G et al (2011) Type 1 diabetes mellitus and celiac disease: endothelial dysfunction. Acta Diabetol doi:10.​1007/​s00592-011-0301-1
2.
Hirsch IB (2005) Glycemic varability: it’s not just about anymore!. Diabetes Technol Ther 7(5):780–783PubMedCrossRef
3.
Hansen D, Brock-Jacobsen B, Lund E, Bjørn C, Hansen LP, Nielsen C et al (2006) Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years’ follow-up. Diabetes Care 29:2452–2456PubMedCrossRef
4.
Amin R, Murphy N, Edge J, Ahmed ML, Acerini CL, Dunger DB (2002) A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease. Diabetes 25:1117–1122
5.
Kaspers S, Kordonouri O, Shober E, Grabert M, Hauffa B, Holl R (2004) Anthropometry, metabolic control, and thyroid autoimmunity in type 1 diabetes with celiac disease: a multicenter survey. J Pediatr 145:790–795PubMedCrossRef
6.
Saadah OI, Zacharin M, O’Callaghan A, Oliver MR, Catto-Smith AG (2004) Effect of gluten-free diet and adherence on growth and diabetic control in diabetics with coeliac disease. Arch Dis Child 89:871–876PubMedCrossRef
7.
Sanchez-Albisua I, Wolf J, Neu A, Geigert H, Wäscher I, Stern M (2005) Coeliac disease in children with Type 1 diabetes mellitus: the effect of the gluten-free diet. Diabet Med 22:1079–1082PubMedCrossRef
8.
Barera G, Bonfanti R, Viscardi M, Bazzigaluppi E, Calori G, Meschi F et al (2002) Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 109:833–838PubMedCrossRef
9.
Hansen D, Bennedbaek FN, Hansen LK, Hoier-Madsen M, Hegedus L, Jacobsen BB, Husby S (2001) High prevalence of coeliac disease in Danish children with type I diabetes mellitus. Acta Paediatr 90:1238–1243PubMedCrossRef
10.
Saukkonen T, Vaisanen S, Akerblom HK, Savilahti E (2002) Childhood diabetes in finland study group. Celiac disease in children and adolescents with type 1 diabetes: a study of growth, glycaemic control, and experiences of families. Acta Paediatr 91:297–302PubMedCrossRef
Metadata
Title
Type 1 diabetes mellitus and celiac disease: usefulness of gluten-free diet
Authors
Paola Pascolo
Elena Faleschini
Giorgio Tonini
Alessandro Ventura
Publication date
01-10-2013
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 5/2013
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-011-0316-7

Other articles of this Issue 5/2013

Acta Diabetologica 5/2013 Go to the issue

Letter to the Editor

Comment on: acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus

Letter to the Editor

Fabp4-Cre-mediated deletion of the miRNA-processing enzyme Dicer causes mouse embryonic lethality

Review Article

Association between type 2 diabetes and rs10811661 polymorphism upstream of CDKN2A/B: a meta-analysis

Short Communication

Cystatin C is not a good candidate biomarker for HNF1A-MODY

Original Article

Economic status and clinical care in young type 1 diabetes patients: a nationwide multicenter study in Brazil

Original Article

TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits